Parallel Advisors »

Artiva Biotherapeutics shares owned by Parallel Advisors

Quarter-by-quarter ownership of Artiva Biotherapeutics (ARTV) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Artiva Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Artiva Biotherapeutics held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Artiva Biotherapeutics by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2026-09-30 $520 73 7.12

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Corcept Therapeutics Stock (CORT)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Microsoft Stock (MSFT)
Google Stock (GOOGL)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Amazon.com Stock (AMZN)
Avantis International Equity Etf Etf (AVDE)
Victoryshares Free Cash Flow Etf Etf (VFLO)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Vanguard Large Cap Etf (VV)
Cvb Finl Corp Stock (CVBF)

View all positions for Parallel Advisors

Top funds holding Artiva Biotherapeutics

RA Capital Management
Viking Global Investors
Blackstone Group
5AM Venture Management
VR Adviser
Franklin Resources
Caligan Partners
Vanguard Capital Management
Samsara BioCapital
Blue Owl Capital Holdings
Propel Bio Management
BlackRock
Citadel Advisors
Geode Capital Management
Silverarc Capital Management

View all funds holding Artiva Biotherapeutics